DNA methylation patterns in cancer: novel prognostic indicators?

Michael C Frühwald1

  • 1Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Albert-Schweitzer-Strasse 33, Muenster, Germany. fruhwald@uni-muenster.de

American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|August 22, 2003
PubMed
Summary

Aberrant DNA methylation patterns are crucial in cancer development and progression. These epigenetic changes offer potential as biomarkers for prognosis and therapeutic targets in various cancers.